Concentrix Corporation (CNXC)
Official siteTECHNOLOGY • INFORMATION TECHNOLOGY SERVICES • NASDAQ
Market Cap: $2.00B
Last updated: Nov 17, 2026 at 11:05 AM ET
Concentrix Corporation (CNXC) Stock Forecast
Analysts expect Concentrix (CNXC) to earn $11.05 per share in the fiscal year ending Nov 30, 2026, on revenue of $9.85B. Of 4 analysts, 3 rate the stock Buy or Strong Buy, 1 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 3 estimates for the fiscal year ending Nov 30, 2026 were revised up and 0 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 4 ratings average 2.00, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 75% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 25.0% |
| Buy | 2 | 50.0% |
| Hold | 1 | 25.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 4
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 4.3% and revenue estimates fall 0.3%.
- Fiscal year ending Nov 30, 2026
- $11.05
- EPS consensus, revenue $9.85B
- Fiscal year ending Nov 30, 2027
- $11.52
- EPS consensus, revenue $9.82B
- Next report
- Jan 11, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Nov 30, 2026 | $11.05 | $10.98 to $11.10 | 5 | $9.85B | $9.83B to $9.87B | 5 |
| Nov 30, 2027 | $11.52 | $10.95 to $11.78 | 5 | $9.82B | $9.64B to $9.92B | 5 |
Quarterly Estimates
The EPS consensus falls from $2.98 for the quarter ending Nov 30, 2026 to $2.81 for the quarter ending Feb 28, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Nov 30, 2026 | $2.98 | $2.84 to $3.09 | 6 | $2.49B | $2.39B to $2.58B | 6 |
| Feb 28, 2027 | $2.81 | $2.62 to $2.97 | 3 | $2.43B | $2.40B to $2.47B | 3 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 6 upward and 2 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Nov 30, 2026 | 3 | 0 |
| Fiscal year ending Nov 30, 2027 | 1 | 2 |
| Quarter ending Feb 28, 2027 | 2 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Nov 30, 2026 has fallen 1.3% from $11.20.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Nov 30, 2026 | $11.05 | $11.05 | $10.97 | $11.20 | $11.20 | -1.3% |
| Fiscal year ending Nov 30, 2027 | $11.52 | $11.52 | $11.58 | $11.89 | $11.89 | -3.1% |
| Quarter ending Feb 28, 2027 | $2.81 | $2.85 | $2.85 | $2.85 | $2.85 | -1.3% |
Frequently Asked Questions About CNXC
What is the CNXC stock forecast?
Consensus analyst estimates put Concentrix's EPS at $11.05 for the fiscal year ending Nov 30, 2026, on revenue of $9.85B. The consensus rating from 4 analysts is Buy.
How do analysts rate CNXC stock?
Of 4 analysts covering Concentrix, 1 rates it Strong Buy, 2 Buy, 1 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from CNXC next year?
For the fiscal year ending Nov 30, 2026, the consensus EPS estimate is $11.05, with estimates from $10.98 to $11.10 from 5 analysts. For the fiscal year ending Nov 30, 2027, the consensus EPS estimate is $11.52, with estimates from $10.95 to $11.78 from 5 analysts.
What revenue do analysts expect from Concentrix next year?
For the fiscal year ending Nov 30, 2026, the consensus revenue estimate is $9.85B, with estimates from $9.83B to $9.87B. For the fiscal year ending Nov 30, 2027, the consensus revenue estimate is $9.82B, with estimates from $9.64B to $9.92B.
How many analysts cover CNXC?
4 analysts rate Concentrix stock, and 5 analysts estimate its EPS for the fiscal year ending Nov 30, 2026.
CNXC pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts